8974 Federal Register / Vol. 75, No. 38 / Friday, February 26, 2010 / Notices 

any purpose at anytime. Additionally, 

CMS staff is prohibited from taking such 

actions on behalf of a visitor or utilizing 

any removable media provided by a 

visitor. 

Attendees that are Foreign Nationals 

(reside outside the U.S.) need to identify 

themselves as such, and provide the 

following information for security 

clearance to the public meeting 

coordinator by the date specified in the 

DATES section of this notice: 

• Visitor’s full name (as it appears on 

passport); 

• Gender; 

• Country of origin and citizenship; 

• Biographical data and related 

information; 

• Date of birth; 

• Place of birth; 

• Passport number; 

• Passport issue date; 

• Passport expiration date; and 

• Dates of visits. 

Individuals who are not registered in 

advance will not be permitted to enter 

the building and will be unable to 

attend the meeting. The public may not 

enter the building earlier than 45 

minutes before the convening of the 

meeting each day. 

Security measures will also include 

inspection of vehicles, inside and 

outside, at the entrance to the grounds 

and buildings. In addition, all persons 

entering the building must pass through 

a metal detector. All items brought to 

CMS are subject to inspection. We 

cannot assume responsibility for 

coordinating the receipt, transfer, 

transport, storage, set-up, safety, or 

timely arrival of any personal 

belongings or items used for 

demonstration or to support a 

presentation. Special arrangements and 

approvals are required in order to bring 

pieces of equipment or medical devices 

at least 2 weeks prior to each public 

meeting. These arrangements need to be 

made with the public meeting 

coordinator. It is possible that certain 

requests made in advance of the public 

meeting could be denied because of 

unique safety, security or handling 

issues related to the equipment. A 

minimum of 2 weeks is required for 

approvals and security procedures. Any 

request not submitted at least 2 weeks 

in advance of the public meeting will be 

denied. 

Parking permits and instructions are 

issued upon arrival by the guards at the 

main entrance. 

All visitors must be escorted by 

agency staff in order to enter areas other 

than the public areas on the lower and 

first-floor levels in the Central Building. 

Authority: Section 1102 and 1871 of the 

Social Security Act (42 U.S.C. 1302 and 42 

U.S.C. 1395hh). 

Dated: February 18, 2010. 

Charlene Frizzera, 

Acting Adminstrator, Centers for Medicare 

& Medicaid Services. 

[FR Doc. 2010–3722 Filed 2–25–10; 8:45 am] 

BILLING CODE 4120–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Eunice Kennedy Shriver National 

Institute of Child Health & Human 

Development; Notice of Closed 

Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. App.), notice is 

hereby given of the following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute of 

Child Health and Human Development 

Special Emphasis Panel; Maternal and Child 

Health in Poor Countries: Evidence from 

Randomized Evaluations. 

Date: March 18, 2010. 

Time: 11 a.m. to 2:30 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6100 

Executive Boulevard, Room 5B01, Rockville, 

MD 20852.(Telephone Conference Call) 

Contact Person: Carla T. Walls, PhD, 

Scientific Review Officer, Division of 

Scientific Review, Eunice Kennedy Shriver 

National Institute of Child Health and 

Human Development, NIH, 6100 Executive 

Blvd., Room 5B01, Bethesda, MD 20892, 

(301) 435–6898, wallsc@mail.nih.gov. 

This notice is being published less than 15 

days prior to the meeting due to the closing 

of the Federal Government the week of 

February 7, 2010. The Federal Government 

was closed due to inclement weather 

conditions. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.864, Population Research; 

93.865, Research for Mothers and Children; 

93.929, Center for Medical Rehabilitation 

Research; 93.209, Contraception and 

Infertility Loan Repayment Program, National 

Institutes of Health, HHS) 

Dated: February 19, 2010. 

Jennifer Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2010–4081 Filed 2–25–10; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Office of the Director, National 

Institutes of Health; Notice of Meeting 

Pursuant to section 10(a) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. App.), notice is 

hereby given of a meeting of the 

Scientific Management Review Board. 

The NIH Reform Act of 2006 (Pub. L. 

109–482) provides organizational 

authorities to HHS and NIH officials to: 

(1) Establish or abolish national research 

institutes; (2) reorganize the offices 

within the Office of the Director, NIH 

including adding, removing, or 

transferring the functions of such offices 

or establishing or terminating such 

offices; and (3) reorganize, divisions, 

centers, or other administrative units 

within an NIH national research 

institute or national center including 

adding, removing, or transferring the 

functions of such units, or establishing 

or terminating such units. The purpose 

of the Scientific Management Review 

Board (also referred to as SMRB or 

Board) is to advise appropriate HHS and 

NIH officials on the use of these 

organizational authorities and identify 

the reasons underlying the 

recommendations. 

The meeting will be open to the 

public, with attendance limited to space 

available. Individuals who plan to 

attend and need special assistance, such 

as sign language interpretation or other 

reasonable accommodations, should 

notify the Contact Person listed below 

in advance of the meeting. 

Name of Committee: Scientific 

Management Review Board. 

Date: March 10, 2010. 

Time: 8 a.m. to 4:30 p.m. 

Agenda: Presentation and discussion will 

include updates from SMRB Working 

Groups; Deliberating Organization Change 

and Effectiveness; NIH Intramural Research 

Program; and Substance Use, Abuse, and 

Addiction. The Board will also discuss 

perspectives on organizational change. Time 

will be allotted on the agenda for public 

comment. Sign up for public comment will 

begin at approximately 7 a.m. and will be 

restricted to one sign in per person. In the 

event that time does not allow for all those 

interested to present oral comments, anyone 

may file written comments using the contact 

person address below. 


sroberts on DSKD5P82C1PROD with NOTICES
Federal Register / Vol. 75, No. 38 / Friday, February 26, 2010 / Notices 8975 

Place: National Institutes of Health, 

Building 31, 6th Floor, Conference Room 6, 

31 Center Drive, Bethesda, MD 20892. 

Contact Person: Lyric Jorgenson, PhD, 

Office of Science Policy, Office of the 

Director, National Institutes of Health, 

Building 1, Room 218, MSC 0166, 9000 

Rockville Pike, Bethesda, MD 20892, 

smrb@mail.nih.gov, (301) 496–6837. 

This meeting is being published less than 

15 days prior to the meeting due to 

scheduling conflicts of the Members. 

Any interested person may file written 

comments with the committee by forwarding 

the statement to the Contact Person listed on 

this notice. The statement should include the 

name, address, telephone number and when 

applicable, the business or professional 

affiliation of the interested person. 

The meeting will also be webcast. The draft 

meeting agenda and other information about 

the SMRB, including information about 

access to the webcast, will be available at 

http://smrb.od.nih.gov. 

In the interest of security, NIH has 

instituted stringent procedures for entrance 

onto the NIH campus. All visitor vehicles, 

including taxis, hotel, and airport shuttles 

will be inspected before being allowed on 

campus. Visitors will be asked to show one 

form of identification (for example, a 

government-issued photo ID, driver’s license, 

or passport) and to state the purpose of their 

visit. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.14, Intramural Research 

Training Award; 93.22, Clinical Research 

Loan Repayment Program for Individuals 

from Disadvantaged Backgrounds; 93.232, 

Loan Repayment Program for Research 

Generally; 93.39, Academic Research 

Enhancement Award; 93.936, NIH Acquired 

Immunodeficiency Syndrome Research Loan 

Repayment Program; 93.187, Undergraduate 

Scholarship Program for Individuals from 

Disadvantaged Backgrounds, National 

Institutes of Health, HHS) 

Dated: February 22, 2010. 

Jennifer Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2010–4080 Filed 2–25–10; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of General Medical 

Sciences; Notice of Closed Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. App.), notice is 

hereby given of the following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute of 

General Medical Sciences Special Emphasis 

Panel; Review of Minority Biomedical 

Research Support Chemistry Applications. 

Date: March 18–19, 2010. 

Time: 8:30 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Hyatt Regency, Bethesda, MD 20814. 

Contact Person: John J. Laffan, PhD, 

Scientific Review Officer, Office of Scientific 

Review, National Institute of General Medical 

Sciences, National Institutes of 

Health,Natcher Building, Room 3AN18J, 

Bethesda, MD 20892, 301–594–2773, 

laffanjo@mail.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.375, Minority Biomedical 

Research Support; 93.821, Cell Biology and 

Biophysics Research; 93.859, Pharmacology, 

Physiology, and Biological Chemistry 

Research; 93.862, Genetics and 

Developmental Biology Research; 93.88, 

Minority Access to Research Careers; 93.96, 

Special Minority Initiatives, National 

Institutes of Health, HHS) 

Dated: February 19, 2010. 

Jennifer Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2010–3922 Filed 2–25–10; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of Allergy and 

Infectious Diseases; Notice of Closed 

Meetings 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. App.), notice is 

hereby given of the following meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute of 

Allergy and Infectious Diseases Special 

Emphasis Panel, Consortium of Food Allergy 

Research (CoFAR) and CoFAR Statistical and 

Clinical Coordinating Center (CoFAR 

SACCC) (U19 and U01). 

Date: March 11–12, 2010. 

Time: 8 a.m. to 6 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Holiday Inn Georgetown, 2101 

Wisconsin Avenue, NW., Washington, DC 

20007. 

Contact Person: Wendy F. Davidson, PhD, 

Scientific Review Officer, Scientific Review 

Program, Division of Extramural Activities, 

NIH/NIAID/DHHS, 6700B Rockledge Drive, 

MSC 7616, Bethesda, MD 20892–7616. 301– 

402–8399, davidsonw@niaid.nih.gov. 

This notice is being published less than 15 

days prior to the meeting due to the timing 

limitations imposed by the review and 

funding cycle. 

Name of Committee: National Institute of 

Allergy and Infectious Diseases Special 

Emphasis Panel, Enterics Research 

Investigational Network Cooperative 

Research Centers (ERIN). 

Date: March 17–18, 2010. 

Time: 8 a.m. to 6 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Crowne Plaza Hotel—Silver Spring, 

8777 Georgia Avenue, Silver Spring, MD 

20910. 

Contact Person: Brenda Lange-Gustafson, 

PhD, Scientific Review Officer, NIAID/NIH/ 

DHHS, Scientific Review Program, Room 

3122, 6700–B Rockledge Drive, MSC–7616, 

Bethesda, MD 20892–7616, 301–451–3684, 

bgustafson@niaid.nih.gov. 

Name of Committee: Microbiology, 

Infectious Diseases and AIDS Initial Review 

Group, Acquired Immunodeficiency 

Syndrome Research Review Committee. 

Date: March 18–19, 2010. 

Time: 8 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Hyatt Regency Bethesda, One 

Bethesda Metro Center, 7400 Wisconsin 

Avenue, Bethesda, MD 20814. 

Contact Person: Erica L. Brown, PhD, 

Scientific Review Officer, Scientific Review 

Program, Division of Extramural Activities, 

National Institutes of Health/NIAID, 6700B 

Rockledge Drive, MSC 7616, Bethesda, MD 

20892–7616, 301–451–2639, 

ebrown@niaid.nih.gov. 

Name of Committee: National Institute of 

Allergy and Infectious Diseases Special 

Emphasis Panel, SARS Review. 

Date: March 18, 2010. 

Time: 11 a.m. to 2 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6700B 

Rockledge Drive, Bethesda, MD 20817. 

Contact Person: Roberta Binder, PhD, 

Scientific Review Officer, Scientific Review 

Program, Division of Extramural Activities, 

NIAID/NIH/DHHS, 6700B Rockledge Drive, 

MSC 7616, Bethesda, MD 20892, (301) 496– 

7966, rbinder@niaid.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.855, Allergy, Immunology, 

and Transplantation Research; 93.856, 

Microbiology and Infectious Diseases 

Research, National Institutes of Health, HHS) 


sroberts on DSKD5P82C1PROD with NOTICES